← All companies

IGC

IGC Pharma, Inc.

IGC NYSE Pharmaceutical Preparations EDGAR ↗

$0.25

-0.01 -2.00%

Key statistics

from XBRL data in SEC filings

Market cap

$24.5M

Revenue (TTM)

$1.17M

Net income (TTM)

-$7.02M

EPS (TTM)

$-0.08

P/E ratio

—

Dividend yield

—

Free cash flow

-$4.91M

Cash

$207K

Total assets

$9.19M

Gross margin

39.6%

52-week range

$0.24 – $0.50

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Jul 14, 2026 8-K Entered a material agreement; Unregistered sale of equity Jul 6, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jun 8, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Apr 20, 2026 8-K Other events Mar 30, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 12, 2026 8-K Entered a material agreement Jan 6, 2026 8-K Amended charter or bylaws Jan 2, 2026 8-K Amended charter or bylaws Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Completed an acquisition or disposition Nov 14, 2025 8-K Shareholder vote results; Other events Oct 14, 2025 8-K Entered a material agreement Oct 1, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-K Fiscal year ended 2025-03-31 Jun 27, 2025 8-K Other events Jun 17, 2025 10-Q Quarter ended 2024-12-31 Feb 14, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Entered a material agreement; Unregistered sale of equity Sep 27, 2024 8-K Shareholder vote results; Other events Aug 27, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Entered a material agreement; Took on a direct financial obligation Aug 2, 2024 10-K Fiscal year ended 2024-03-31 Jun 24, 2024 8-K Regulation FD disclosure; Other events Apr 5, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 28, 2024 8-K Entered a material agreement Mar 22, 2024 8-K Director or officer change; Regulation FD disclosure Mar 13, 2024 10-Q Quarter ended 2023-12-31 Feb 14, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Entered a material agreement Oct 27, 2023 8-K Shareholder vote results; Other events Aug 21, 2023 10-Q Quarter ended 2023-06-30 Aug 10, 2023 10-K Fiscal year ended 2023-03-31 Jul 7, 2023 8-K Entered a material agreement; Took on a direct financial obligation Jul 7, 2023 8-K Entered a material agreement; Unregistered sale of equity Jul 7, 2023 8-K Director or officer change May 8, 2023 8-K Amended charter or bylaws; Regulation FD disclosure Mar 21, 2023 10-Q Quarter ended 2022-12-31 Feb 14, 2023 8-K Director or officer change Dec 29, 2022